BioDuro and Cenra Launch Joint Venture to Expand Resilient Global API Manufacturing Capacity
IRVINE, California, March 3, 2026 – BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has established a joint venture with Cenra API Solutions, also as known as Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), a leading pharmaceutical chemical manufacturer in Taiwan since 1964, to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.
March 03, 2026